143 related articles for article (PubMed ID: 35104324)
21. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
22. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
[TBL] [Abstract][Full Text] [Related]
23. Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells.
Rauch BH; Millette E; Kenagy RD; Daum G; Clowes AW
Circ Res; 2004 Feb; 94(3):340-5. PubMed ID: 14670838
[TBL] [Abstract][Full Text] [Related]
24. Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis.
Moran CS; Seto SW; Krishna SM; Sharma S; Jose RJ; Biros E; Wang Y; Morton SK; Golledge J
Sci Rep; 2017 Feb; 7():43079. PubMed ID: 28220880
[TBL] [Abstract][Full Text] [Related]
25. Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.
Borensztajn K; Peppelenbosch MP; Spek CA
Trends Mol Med; 2008 Oct; 14(10):429-40. PubMed ID: 18774340
[TBL] [Abstract][Full Text] [Related]
26. Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation.
Borensztajn KS; Bijlsma MF; Groot AP; Brüggemann LW; Versteeg HH; Reitsma PH; Peppelenbosch MP; Spek CA
Exp Cell Res; 2007 Jul; 313(12):2622-33. PubMed ID: 17531220
[TBL] [Abstract][Full Text] [Related]
27. 15-PGDH/15-KETE plays a role in hypoxia-induced pulmonary vascular remodeling through ERK1/2-dependent PAR-2 pathway.
Wei L; Yu X; Shi H; Zhang B; Lian M; Li J; Shen T; Xing Y; Zhu D
Cell Signal; 2014 Jul; 26(7):1476-88. PubMed ID: 24657469
[TBL] [Abstract][Full Text] [Related]
28. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
[TBL] [Abstract][Full Text] [Related]
29. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
30. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
[TBL] [Abstract][Full Text] [Related]
31. Thrombin and factor Xa link the coagulation system with liver fibrosis.
Dhar A; Sadiq F; Anstee QM; Levene AP; Goldin RD; Thursz MR
BMC Gastroenterol; 2018 May; 18(1):60. PubMed ID: 29739329
[TBL] [Abstract][Full Text] [Related]
32. The role of protease-activated receptors PAR-1 and PAR-2 in the repair of 16HBE 14o(-) epithelial cell monolayers in vitro.
Ewen D; Clarke SL; Smith JR; Berger C; Salmon G; Trevethick M; Shute JK
Clin Exp Allergy; 2010 Mar; 40(3):435-49. PubMed ID: 20210813
[TBL] [Abstract][Full Text] [Related]
33. Xa inhibitor edoxaban ameliorates hepatic ischemia-reperfusion injury via PAR-2-ERK 1/2 pathway.
Maeda K; Kuriyama N; Noguchi D; Ito T; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Murata Y; Tanemura A; Kishiwada M; Mizuno S
PLoS One; 2024; 19(5):e0292628. PubMed ID: 38748746
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of naïve monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only.
Nieuwenhuizen L; Falkenburg WJ; Schutgens RE; Roosendaal G; van Veghel K; Biesma DH; Lafeber FP
Scand J Immunol; 2013 May; 77(5):339-49. PubMed ID: 23421536
[TBL] [Abstract][Full Text] [Related]
35. Emerging roles of protease-activated receptors in cardiometabolic disorders.
Hara T; Sata M; Fukuda D
J Cardiol; 2023 Apr; 81(4):337-346. PubMed ID: 36195252
[TBL] [Abstract][Full Text] [Related]
36. Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.
Ten Freyhaus H; Berghausen EM; Janssen W; Leuchs M; Zierden M; Murmann K; Klinke A; Vantler M; Caglayan E; Kramer T; Baldus S; Schermuly RT; Tallquist MD; Rosenkranz S
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1236-45. PubMed ID: 25745058
[TBL] [Abstract][Full Text] [Related]
37. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
38. Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension.
Kuwabara Y; Tanaka-Ishikawa M; Abe K; Hirano M; Hirooka Y; Tsutsui H; Sunagawa K; Hirano K
Cardiovasc Res; 2019 Jul; 115(8):1357-1368. PubMed ID: 30423156
[TBL] [Abstract][Full Text] [Related]
39. Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.
Jiang R; Wang NP; Tanaka KA; Levy JH; Guyton RA; Zhao ZQ; Vinten-Johansen J
J Surg Res; 2011 Aug; 169(2):319-27. PubMed ID: 20451919
[TBL] [Abstract][Full Text] [Related]
40. Coagulation cascade proteases and tissue fibrosis.
Chambers RC; Laurent GJ
Biochem Soc Trans; 2002 Apr; 30(2):194-200. PubMed ID: 12023850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
